Literature DB >> 26678157

Physical exercise mitigates doxorubicin-induced brain cortex and cerebellum mitochondrial alterations and cellular quality control signaling.

I Marques-Aleixo1, E Santos-Alves2, M M Balça2, P I Moreira3, P J Oliveira4, J Magalhães2, A Ascensão2.   

Abstract

Doxorubicin (DOX) is a highly effective anti-neoplastic agent, whose clinical use is limited by a dose-dependent mitochondrial toxicity in non-target tissues, including the brain. Here we analyzed the effects of distinct exercise modalities (12-week endurance treadmill-TM or voluntary free-wheel activity-FW) performed before and during sub-chronic DOX treatment on brain cortex and cerebellum mitochondrial bioenergetics, oxidative stress, permeability transition pore (mPTP), and proteins involved in mitochondrial biogenesis, apoptosis and auto(mito)phagy. Male Sprague-Dawley rats were divided into saline-sedentary (SAL+SED), DOX-sedentary (DOX+SED; 7-week DOX (2 mg · kg(-1)per week)), DOX+TM and DOX+FW. Animal behavior and post-sacrifice mitochondrial function were assessed. Oxidative phosphorylation (OXPHOS) subunits, oxidative stress markers or related proteins (SIRT3, p66shc, UCP2, carbonyls, MDA, -SH, aconitase, Mn-SOD), as well as proteins involved in mitochondrial biogenesis (PGC1α and TFAM) were evaluated. Apoptotic signaling was followed through caspases 3, 8 and 9-like activities, Bax, Bcl2, CypD, ANT and cofilin expression. Mitochondrial dynamics (Mfn1, Mfn2, OPA1 and DRP1) and auto(mito)phagy (LC3II, Beclin1, Pink1, Parkin and p62)-related proteins were measured by semi-quantitative Western blotting. DOX impaired behavioral performance, mitochondrial function, including lower resistance to mPTP and increased apoptotic signaling, decreased the content in OXPHOS complex subunits and increased oxidative stress in brain cortex and cerebellum. Molecular markers of mitochondrial biogenesis, dynamics and autophagy were also altered by DOX treatment in both brain subareas. Generally, TM and FW were able to mitigate DOX-related impairments in brain cortex and cerebellum mitochondrial activity, mPTP and apoptotic signaling. We conclude that the alterations in mitochondrial biogenesis, dynamics and autophagy markers induced by exercise performed before and during treatment may contribute to the observed protective brain cortex and cerebellum mitochondrial phenotype, which is more resistant to oxidative damage and apoptotic signaling in sub-chronically DOX treated animals.
Copyright © 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Keywords:  Adriamycin; Apoptosis; Autophagy signaling; Brain bioenergetics; Exercise; Mitochondrial dynamics

Mesh:

Substances:

Year:  2015        PMID: 26678157     DOI: 10.1016/j.mito.2015.12.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  10 in total

1.  Treadmill Exercise Attenuates Aβ-Induced Mitochondrial Dysfunction and Enhances Mitophagy Activity in APP/PS1 Transgenic Mice.

Authors:  Na Zhao; Qing-Wei Yan; Jie Xia; Xian-Liang Zhang; Bai-Xia Li; Ling-Yu Yin; Bo Xu
Journal:  Neurochem Res       Date:  2020-03-03       Impact factor: 3.996

Review 2.  Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.

Authors:  Giovana R Onzi; Nathalia D'Agustini; Solange C Garcia; Silvia S Guterres; Paula R Pohlmann; Daniela D Rosa; Adriana R Pohlmann
Journal:  Drug Saf       Date:  2022-05-23       Impact factor: 5.606

3.  Neuroprotective effect of treadmill exercise possibly via regulation of lysosomal degradation molecules in mice with pharmacologically induced Parkinson's disease.

Authors:  Dong-Joo Hwang; Jung-Hoon Koo; Ki-Cheon Kwon; Dong-Hoon Choi; Sung-Deuk Shin; Jae-Hoon Jeong; Hyun-Seob Um; Joon-Yong Cho
Journal:  J Physiol Sci       Date:  2017-12-19       Impact factor: 2.781

4.  Attenuation of doxorubicin-induced oxidative damage in rat brain by regulating amino acid homeostasis with Astragali Radix.

Authors:  Xinyue Yu; Linling Guo; Xiaoying Deng; Fang Yang; Yuan Tian; Peifang Liu; Fengguo Xu; Zunjian Zhang; Yin Huang
Journal:  Amino Acids       Date:  2021-05-04       Impact factor: 3.520

5.  Polyphyllin I induces mitophagic and apoptotic cell death in human breast cancer cells by increasing mitochondrial PINK1 levels.

Authors:  Guo-Bing Li; Ruo-Qiu Fu; Han-Ming Shen; Jing Zhou; Xiao-Ye Hu; Yan-Xia Liu; Yu-Nong Li; Hong-Wei Zhang; Xin Liu; Yan-Hao Zhang; Cheng Huang; Rong Zhang; Ning Gao
Journal:  Oncotarget       Date:  2017-02-07

Review 6.  Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease.

Authors:  Jelena Stevanović; Jorge Beleza; Pedro Coxito; António Ascensão; José Magalhães
Journal:  Mol Metab       Date:  2019-11-29       Impact factor: 7.422

Review 7.  Mechanisms, Mediators, and Moderators of the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Kaitlin H Chung; Susanna B Park; Fiona Streckmann; Joachim Wiskemann; Nimish Mohile; Amber S Kleckner; Luana Colloca; Susan G Dorsey; Ian R Kleckner
Journal:  Cancers (Basel)       Date:  2022-02-26       Impact factor: 6.575

8.  Association between physical exercise, executive function, and cerebellar cortex: A cross-sectional study among the elderly in Chinese communities.

Authors:  Wei Li; Yong Li; Yaopian Chen; Ling Yue; Shifu Xiao
Journal:  Front Aging Neurosci       Date:  2022-08-23       Impact factor: 5.702

9.  Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.

Authors:  Hai-Ning Wang; Ji-Lin Li; Tan Xu; Huai-Qi Yao; Gui-Hua Chen; Jing Hu
Journal:  Mol Med Rep       Date:  2020-05-28       Impact factor: 2.952

10.  Physical exercise may exert its therapeutic influence on Alzheimer's disease through the reversal of mitochondrial dysfunction via SIRT1-FOXO1/3-PINK1-Parkin-mediated mitophagy.

Authors:  Na Zhao; Jie Xia; Bo Xu
Journal:  J Sport Health Sci       Date:  2020-08-28       Impact factor: 7.179

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.